"We're not spilling the beans just yet"

Nanobles Corporation has announced its new product, Thermonoids.

The company has described Thermonoids as a "leap in cannabinoid science". While the exact process and capabilities of Thermonoids remain confidential, Nanobles CEO Mike Robinson has revealed that the technology represents a "thermodynamic marvel" with the potential to unlock untapped benefits from cannabinoids.

"We're not spilling the beans just yet," said Mike Robinson, CEO of Nanobles. "But I can tell you this - Thermonoids are unlike anything the cannabis industry has ever seen. These aren't just another cannabinoid product; it's a paradigm shift that will redefine how we think about bioavailability, stability, and cannabinoid applications."

Thermodynamics in healthcare refers to studying and applying energy transformations and principles—such as heat, work, and entropy—to biological systems and medical innovations. This field is critical for understanding how energy flows and interacts within the human body, particularly at the cellular and molecular levels.

"Thermodynamics is foundational in comprehending metabolic processes, where chemical energy from nutrients is converted into usable energy (ATP) to sustain life functions," stated the entity Operations manager, David Uhalley. "It also drives advancements in drug delivery systems, where controlled thermodynamic principles ensure therapeutic agents' stability, solubility, and targeted release."

Anticipation
While the industry speculates about Thermonoids potential, Robinson encourages the scientific community, healthcare professionals, and industry leaders to stay tuned as he seeks Joint Venture partners and funding for the project.